Micrometastasis in Gastrointestinal Cancer

University of Oslo (UIO)

Status: Unknown

Conditions: Pancreatic Adenocarcinoma; Colorectal Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01919151

93-08172d6.2008.540

Details and patient eligibility

About

Prognostic and predictive value of assessing the patients micrometastasis status in blood and bone marrow when diagnosed GI cancer. 2 different patient subgroups are currently studied, patients with cancer of the pancreas and patients with liver metastasis secondary to colorectal cancer.

Our hypothesis is that patients with detective circulating tumor cells in the blood or disseminated tumour cells in their bone marrow at diagnosis have a more advanced disease than negative patients. This information may be of therapeutic interest.

Full description

Oncological and overall outcome of the included patients are consecutively registrated at the out-patient clinic. At end of follow-up these survival data are analysed according to the presence of tumor cells in blood and bone marrow, and the prognostic impact of their presence are assessed.

Enrollment: 500 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Histological proven adenocarcinoma of the pancreas
2. Histological/radiological verified colorectal liver metastases
3. Consent capable patient
4. Signed written, informed consent

Exclusion criteria

1. Patient'history of other malignancy

Trial design

500 participants in 1 patient group

Gastrointestinal cancer patients

Description:

Patients with radiological suspected cancer in the pancreas Patients with radiological suspected colorectal liver metastasis